HomeBusiness NewsFDA approves Eli Lilly's tirzepatide for weight loss, paving way for wider... Business NewsFinance November 9, 2023 FDA approves Eli Lilly’s tirzepatide for weight loss, paving way for wider use of blockbuster drug By Mathew Share FacebookTwitterPinterestWhatsApp - Advertisement - The obesity approval further establishes Eli Lilly as a formidable competitor to Novo Nordisk in the budding weight loss drug industry… Share FacebookTwitterPinterestWhatsApp Mathewhttp://patriotstribune.org - Advertisement - Stay Connected 16,985FansLike4,568FollowersFollow Must Read Business News Trump writes on social media he no longer plans to testify in civil fraud trial on Monday Admin - December 10, 2023 Business News Top Wall Street analysts are confident about these 3 promising stocks December 10, 2023 Business News Elon Musk reactivates Alex Jones’ X account after a five-year ban December 10, 2023 Business News How grocery stores are becoming data brokers December 10, 2023 Related News Business News Trump writes on social media he no longer plans to testify in civil fraud trial on Monday December 10, 2023 Business News Top Wall Street analysts are confident about these 3 promising stocks December 10, 2023 Business News Elon Musk reactivates Alex Jones’ X account after a five-year ban December 10, 2023 Business News How grocery stores are becoming data brokers December 10, 2023 Business News UPenn President Liz Magill, board chair both resign following backlash over congressional antisemitism testimony December 10, 2023 LEAVE A REPLY Cancel reply Comment: Please enter your comment! Name:* Please enter your name here Email:* You have entered an incorrect email address! Please enter your email address here Website: Save my name, email, and website in this browser for the next time I comment.
